Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 241 - 260 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  MediWound Ltd.

Alterity Therapeutics Enrolls First Patient in the U.S. in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy

Read more ››
By: GlobenewsWire - 16 Mar 2023

UPDATE -- Werewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2023

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Werewolf Therapeutics, Inc.

Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Monte Rosa Therapeutics, Inc.

Pyxis Oncology Announces Dosing of First Subject in Phase 1 Trial of PYX-201, a Novel ADC for Solid Tumors

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Pyxis Oncology

Abeona Therapeutics Announces Acceptance of Abstract on EB-101 Phase 3 VIITAL™ Study Results for Oral Presentation at International Societies for Investigative Dermatology (ISID) 2023 Meeting

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Abeona Therapeutics, Inc.

Paratek Pharmaceuticals Announces Full-Year 2022 Revenue of $160.3 Million

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Paratek Pharmaceuticals, Inc.

Arbutus Doses First Subject in Phase 1 Clinical Trial with its Oral RNA Destabilizer, AB-161

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Arbutus Biopharma Corporation

Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Century Therapeutics, Inc.

Cognition Therapeutics to Report Fourth Quarter and Full Year 2022 Results

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Cognition Therapeutics, Inc.

SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  SeaStar Medical

Reconstituted Amarin Board Ready for the Challenge of Unlocking True Potential of VASCEPA®/VAZKEPA® (Icosapent Ethyl)

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Amarin Corporation plc

Elevar Therapeutics to Present Clinically Supported Poster at AACR 2023 Demonstrating Rivoceranib as a Potent, and Most Selective, TKI for VEGFR-2

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Elevar Therapeutics, Salt Lake City | Elevar Therapeutics

PepGen to Host Fourth Quarter and Full Year 2022 Financial Results Call

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  PepGen Inc.

IN8bio to Present Positive Preclinical Data on Novel Gamma-Delta CAR Platform at AACR Annual Meeting 2023

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  IN8bio Inc.

Comera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Comera Life Sciences Holdings Inc

SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Bruker Daltonics SPR Zweigniederlassung der Bruker Daltonik GmbH | SPR Therapeutics, Inc.

PDS Biotechnology Announces Conference Call and Webcast for Fourth Quarter 2022 Financial Results

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  PDS Biotechnology Corporation

ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product

Read more ››
By: GlobenewsWire - 16 Mar 2023

Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023 

Read more ››
By: GlobenewsWire - 16 Mar 2023
Related companies:  Surface Oncology, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑
{literal} {/literal}